Back to the archive

The encyclopedia · Advertising & PR · Marketing decision · 1973

Geritol sold tiredness as iron-poor blood — and ignored the FTC for years

Jan 1973: J.B. Williams and its agency paid $812K for flouting the FTC's order on Geritol's 'tired blood' claims — tiredness is not a diagnosis.

J.B. Williams Company · 1973-01

What happened

Geritol's advertising told tired Americans that fatigue, lost strength and irritability meant 'iron-poor blood' — and that Geritol would make them feel stronger fast, in seven days. The FTC found the claim false and misleading: those symptoms are common to dozens of conditions, and only a small minority of tired people have the iron deficiency Geritol treats. In 1965 the Commission ordered the ads to say so — an early use of mandatory disclosure.

The Sixth Circuit enforced the order in 1967, holding that concealing Geritol's uselessness for most tired people was a material deception. J.B. Williams and its agency, Parkson, then kept advertising in violation of the order. The government sued in 1970 on eleven counts, and in January 1973 a federal judge found flagrant violations and fined the company and the agency $812,000 — the largest FTC-related penalty of its kind to that point.

The case built two pillars of advertising law: an advertiser must disclose the negative fact that defeats its claim, and a cease-and-desist order is not a suggestion. The agency that wrote the ads was fined beside the brand.

Why it happened

  • Tiredness was sold as a self-diagnosis for iron deficiency — when it is a symptom of dozens of conditions.
  • The ads concealed the negative fact: most tired people have no deficiency and get no benefit.
  • After the order was upheld on appeal, the company and its agency kept running the ads anyway.
What it cost$812K fines, a record thencostly

The lesson

A claim that works by concealing a defeating fact is deceptive, and a cease-and-desist order is not a suggestion: keep advertising after it is upheld and the penalty is priced for contempt.

Aftermath

Geritol stayed on the market under strict advertising restrictions. The case's disclosure logic fed the corrective-advertising remedy the FTC applied to Listerine in 1975 and Doan's Pills in 1999.

Sources

spotted an error? The club wants to know.

Comments · 0

    Sign in to join the comments.

    More like this

    Somewhere, someone solved the problem this company failed at. 2nd Opinion →